Immunitybio Expected Shortfall
| IBRX Stock | | | USD 8.51 0.75 9.66% |
Immunitybio's current Expected Shortfall is presented alongside peer comparisons and related risk metrics.
Current Expected Shortfall Value
A Expected Shortfall of 0 for Immunitybio signals its current reading on this measure. This reflects Immunitybio's positioning relative to its own recent range within Biotechnology.
Compare Immunitybio to PeersMethodology, Assumptions & Data Sources
The current Expected Shortfall for Immunitybio is 0. Immunitybio's Expected Shortfall is computed from historical closing prices over the selected time horizon, applying the indicator's defined mathematical transformation to raw price data. All inputs are based on exchange-reported closing prices, with adjustments for stock splits, dividends, and other corporate actions. Immunitybio operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The output reflects the selected calculation window — changing the horizon will produce different readings. This stock metric is provided for analytical reference.
Other Technical Indicators